Loading clinical trials...

Study Evaluating the Safety of Enbrel (Etanercept) | Clinical Trials | Clareo Health

COMPLETED

Study Evaluating the Safety of Enbrel (Etanercept)

A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection

NCT00683384•Wyeth is now a wholly owned subsidiary of Pfizer

View on ClinicalTrials.gov

Summary

The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All patients from the study center who received or will receive at least one dose of Enbrel according to the approved product indication.

Exclusion Criteria

•Previously discontinued Enbrel therapy due to significant safety concern.

Locations (1)

Metro Manila, Philippines

Key Dates

Start Date

January 1, 2007

Primary Completion Date

October 1, 2009

Completion Date

October 1, 2009

Last Updated

November 16, 2010

Enrollment

ACTUAL participants

Conditions

Arthritis, Psoriatic

Interventions

Etanercept (Enbrel)

DRUG

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

NCT06522035

Arthritis, Psoriatic

View study

NOT_YET_RECRUITING

Pain in Inflammatory Joint Diseases

NCT06718569

ArthritisArthritis, Juvenile Idiopathic+4 more

View study

COMPLETED

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 16, 2010Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study Evaluating the Safety of Enbrel (Etanercept)

Inclusion Criteria

Exclusion Criteria

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

Pain in Inflammatory Joint Diseases

Biologic Treatment Registry Across Canada

A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

Psoriatic Arthritis Pathobiology and Its Relationship With Clinical Disease Activity

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis